Pharma News, 2019

After decades of development and testing the world's first malaria vaccine is beginning a wide roll out, commencing in Malawi before being introduced into Ghana and Kenya over the following weeks.

Osaka (Japan), April 18, 2019 – Maruho Co.

NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)--Pfizer Inc.

The charges against the wholesaler, Rochester Drug Cooperative, and two of its former executives marked a new tactic for prosecutors in tackling the epidemic of addiction to prescription painkillers.

On April 19, 2019, the Food and Drug Administration approved pembrolizumab (KEYTRUDA, Merck & Co.

In a small study of patients referred to the Johns Hopkins Early Psychosis Intervention Clinic (EPIC), Johns Hopkins Medicine researchers report that about half the people referred to the clin...

The promise and challenges of liquid biopsy, an emerging, noninvasive method for targeted disease diagnosis and detection of cancer biomarkers to enable improved and personalized therapy, is the focus...

March 27, 2019 file photo shows a sign explaining the local state of emergency because of a measles outbreak at the Rockland County Health Department in Pomona, N.

Marketing has been approved for the first medical device to treat attention-deficit/hyperactivity disorder (ADHD), the U.

In a first-in-human study of a novel bispecific T-cell engager (BiTE), AMG 420, when administered at a daily dose of 400 mcg, this novel drug-induced responses in 7 of 10 patients with heavily...

A new study concludes that high doses of vitamin D may help hinder the growth of advanced colorectal cancer in combination with chemotherapyA new study concludes that vitamin D might help slow bowel c...

BioAtla and BeiGene entered into a collaboration agreement for the development, production, and commercialization of BioAtla’s BA3071, an investigational anti-CTLA-4 checkpoint blockade antibody.